Abnormal UBA1 activity or ubiquitination causes or drives many human diseases, such as cancer, major neurodegenerative diseases, Angelman syndrome, VEXAS syndrome, and spinal muscular atrophy, as well as aging, highlighting the importance of the discovery of small-molecule modulators of UBA1 activity for research and therapeutic purposes. Here, UBA1 is linked to spinal muscular atrophy.